Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.

McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, Sirima SB, Serry-Bangura A, Habib Beavogui A, Gaddah A, Katwere M, Hendriks J, Keshinro B, Eholie S, Kibuuka H, Kennedy SB, Anzala O, Samai M, D'Ortenzio E, Leigh B, Sow S, Thiébaut R, Greenwood B, Watson-Jones D, Douoguih M, Luhn K, Robinson C

Open source

DOI: 10.1016/j.ebiom.2023.104562
Published: 2023 May
Container: EBioMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2023.104562,
  title = {Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.},
  author = {McLean C and Barry H and Kieh M and Anywaine Z and Tapima Rogers B and Doumbia S and Sirima SB and Serry-Bangura A and Habib Beavogui A and Gaddah A and Katwere M and Hendriks J and Keshinro B and Eholie S and Kibuuka H and Kennedy SB and Anzala O and Samai M and D'Ortenzio E and Leigh B and Sow S and Thiébaut R and Greenwood B and Watson-Jones D and Douoguih M and Luhn K and Robinson C},
  year = {2023},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2023.104562},
  url = {https://doi.org/10.1016/j.ebiom.2023.104562}
}

RIS

TY  - JOUR
TI  - Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.
AU  - McLean C
AU  - Barry H
AU  - Kieh M
AU  - Anywaine Z
AU  - Tapima Rogers B
AU  - Doumbia S
AU  - Sirima SB
AU  - Serry-Bangura A
AU  - Habib Beavogui A
AU  - Gaddah A
AU  - Katwere M
AU  - Hendriks J
AU  - Keshinro B
AU  - Eholie S
AU  - Kibuuka H
AU  - Kennedy SB
AU  - Anzala O
AU  - Samai M
AU  - D'Ortenzio E
AU  - Leigh B
AU  - Sow S
AU  - Thiébaut R
AU  - Greenwood B
AU  - Watson-Jones D
AU  - Douoguih M
AU  - Luhn K
AU  - Robinson C
PY  - 2023
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2023.104562
UR  - https://doi.org/10.1016/j.ebiom.2023.104562
ER  -

APA

C, M., H, B., M, K., Z, A., B, T. R., S, D., SB, S., A, S., A, H. B., A, G., M, K., J, H., B, K., S, E., H, K., SB, K., O, A., M, S., E, D., B, L., S, S., R, T., B, G., D, W., M, D., K, L., & C, R. (2023). Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104562

Source records

pubmed · retrieved 2026-09-27T01:30:27.585Z